Patients Discontinuing Anti-Obesity Jabs Put On Pounds at a Quadrupled Rate Than People Using Diet and Exercise

Fresh analysis suggests that individuals who stop using blockbuster GLP-1 drugs like semaglutide or tirzepatide may regain lost weight much more quickly than those who halt conventional lifestyle regimens.

Findings released in a leading health publication points out that while obese people often shed a large proportion of their total mass while on the medication, the weight comes back at an estimated rate of 0.8 kg per month after stopping.

"Individuals buying these medications must be aware of the danger of quick weight regain when the therapy concludes," warns expert Dr. Susan Jebb.

That rate of regain suggests a return to starting mass within about a year and a half.

Comparing Therapies

The study, which looked at dozens of studies involving over 9,000 of participants, contrasted the outcomes of GLP-1 agonists with older methods.

Scientists emphasize that individuals who shed pounds through diet and exercise usually experience a slower creep back—perhaps 100 grams monthly—after stopping.

The Reason for the Quick Rebound

Nutrition scientists propose the way of the jabs accounts for the accelerated weight return.

The injections copy a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.

"Sustained high doses of the hormone levels several times higher than normal could lead to the body to generate a reduced amount of its endogenous hormone, and may also reduce responsiveness to its effects," explained Dr. Adam Collins, a dietetics researcher.

"Stopping of this GLP-1 'fix' means hunger is unsuppressed, making excessive eating much more probable."

A Lifelong Issue?

Health authorities recommend the jabs for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.

A number of clinicians argue that, considering the likelihood of relapse, the therapy is often long-term.

This view is reinforced by pharmaceutical companies, who state that the results "highlight the chronic nature of excess weight," comparing it to managing conditions like hypertension.

Patient Experiences

People who have come off the medication report a powerful return of cravings.

"It felt as if a trigger that goes on and you're instantly extremely hungry," described a patient.

The struggle is compounded if patients have not developed permanent dietary or behavioural modifications during treatment.

Significant Adoption

Recent estimates suggest that a significant number of people in the UK have used these injections in the past year, with interest continuing to grow.

• Use is more common among females than males.
• The 40s and 50s demographic shows the greatest level of interest.
• A large proportion obtain the drugs through private healthcare rather than the NHS.

In conclusion, clinicians caution that while these medications are powerful tools for shedding pounds, they are not a magic solution and long-term success likely depends on ongoing lifestyle changes.